PolyPeptide's IPO covered on day one

Aidan Gregory

April 21, 2021 11:00 am

Polypeptide_2_alamy_575_375 — 2BH3P0Y Vial with soluble protease proteins for activation of the coronavirus severe acute respiratory syndrome (SARS) trypsin-like protein in human respirato | Alamy Stock Photo

The IPO of PolyPeptide, the Swiss pharmaceutical ingredients company, was covered on the first morning of bookbuilding on Wednesday, according to sources close to the deal.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Switzerland Morgan Stanley Credit Suisse Equity IPOs Equity Europe EMEA

AG

Aidan Gregory